ArticleVaccine2020

Induction of cross-reactive HIV-1 specific antibody responses by engineered V1V2 immunogens with reduced conformational plasticity.

Jennifer I Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.